In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Five-Point Plan For Mastering Customer Preference

Executive Summary

QuintilesIMS' research demonstrates that the preference for one set of digital channels varies widely by HCP specialty and country. A single physician’s channel preference can vary by the disease area for which they receive communication. How can companies, faced with such complexity, ever hope to master customer preference?

You may also be interested in...



Channel Preference Versus Promotional Reality: The Core Challenge Of Multichannel Marketing

Pharma is one of the last industries to hold on to the use of sales representatives to sell its goods. It's time to harness digital technologies that enable multiple ways to approach clients on their own terms.

Growing Established Pharma Products: Three Strategic Imperatives

The global pharmaceutical market has seen a remarkable resurgence of innovation in the past few years, and in this exciting era it's easy to lose sight of the launches of yesteryear that are the established products of today. But for many companies, disease areas and countries, these older brands are the bedrock of business and treatment.

Which Way Now For Mid-Sized European Pharmas?

Compared with their top 20 European peers and with similarly sized companies in the US, many mid-sized European pharmas are struggling. IMS Health analyzes the predicament these companies find themselves in and outlines what they need to do to avoid being caught in an evolutionary backwater.

Topics

UsernamePublicRestriction

Register

IV124437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel